JP2005516952A5 - - Google Patents

Download PDF

Info

Publication number
JP2005516952A5
JP2005516952A5 JP2003554664A JP2003554664A JP2005516952A5 JP 2005516952 A5 JP2005516952 A5 JP 2005516952A5 JP 2003554664 A JP2003554664 A JP 2003554664A JP 2003554664 A JP2003554664 A JP 2003554664A JP 2005516952 A5 JP2005516952 A5 JP 2005516952A5
Authority
JP
Japan
Prior art keywords
compound according
compound
hydrogen
alkyl
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP2003554664A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005516952A (ja
Filing date
Publication date
Priority claimed from GBGB0130339.5A external-priority patent/GB0130339D0/en
Application filed filed Critical
Publication of JP2005516952A publication Critical patent/JP2005516952A/ja
Publication of JP2005516952A5 publication Critical patent/JP2005516952A5/ja
Ceased legal-status Critical Current

Links

JP2003554664A 2001-12-19 2002-12-06 中枢神経系疾患の治療のためのイソクロマン化合物 Ceased JP2005516952A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0130339.5A GB0130339D0 (en) 2001-12-19 2001-12-19 Isochroman compounds
PCT/US2002/036148 WO2003053948A1 (en) 2001-12-19 2002-12-06 Isochroman compounds for treatment of cns disorders

Publications (2)

Publication Number Publication Date
JP2005516952A JP2005516952A (ja) 2005-06-09
JP2005516952A5 true JP2005516952A5 (enExample) 2006-02-02

Family

ID=9927920

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003554664A Ceased JP2005516952A (ja) 2001-12-19 2002-12-06 中枢神経系疾患の治療のためのイソクロマン化合物

Country Status (20)

Country Link
EP (1) EP1458703B1 (enExample)
JP (1) JP2005516952A (enExample)
CN (1) CN1312148C (enExample)
AR (1) AR038662A1 (enExample)
AT (1) ATE355283T1 (enExample)
AU (1) AU2002359378B8 (enExample)
BR (1) BR0214859A (enExample)
CA (1) CA2469278A1 (enExample)
CY (1) CY1106552T1 (enExample)
DE (1) DE60218529T2 (enExample)
DK (1) DK1458703T3 (enExample)
ES (1) ES2280606T3 (enExample)
GB (1) GB0130339D0 (enExample)
MX (1) MXPA04006085A (enExample)
PE (1) PE20030728A1 (enExample)
PT (1) PT1458703E (enExample)
SI (1) SI1458703T1 (enExample)
SV (1) SV2004001441A (enExample)
TW (1) TW200301116A (enExample)
WO (1) WO2003053948A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7534796B2 (en) 2005-02-18 2009-05-19 Wyeth Imidazo[4,5-b]pyridine antagonists of gonadotropin releasing hormone receptor
US7582634B2 (en) 2005-02-18 2009-09-01 Wyeth 7-substituted imidazo[4,5-c]pyridine antagonists of gonadotropin releasing hormone receptor
US7538113B2 (en) 2005-02-18 2009-05-26 Wyeth 4-substituted imidazo[4,5-c]pyridine antagonists of gonadotropin releasing hormone receptor
US7531542B2 (en) 2005-05-18 2009-05-12 Wyeth Benzooxazole and benzothiazole antagonists of gonadotropin releasing hormone receptor
US7582636B2 (en) 2005-05-26 2009-09-01 Wyeth Piperazinylimidazopyridine and piperazinyltriazolopyridine antagonists of Gonadotropin Releasing Hormone receptor
NL2000351C2 (nl) 2005-12-22 2007-09-11 Pfizer Prod Inc Estrogeen-modulatoren.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4247553A (en) * 1977-10-31 1981-01-27 The Upjohn Company Methods of treating psychosis
ES2133714T3 (es) * 1993-12-28 1999-09-16 Upjohn Co Compuestos heterociclicos para el tratamiento de trastornos del snc y cardiovasculares.
MX9710260A (es) * 1995-06-30 1998-03-29 Upjohn Co Isocromanos 1, 6-disustituidos para el tratamiento de migrañas.
GB2370270A (en) * 2000-12-20 2002-06-26 Lilly Co Eli Pharmaceutical compounds

Similar Documents

Publication Publication Date Title
CN1092642C (zh) 用作速激肽nk3受体拮抗剂的喹啉衍生物
JP2005511698A5 (enExample)
JP2006504738A5 (enExample)
JP2005536475A5 (enExample)
JP2012521429A5 (enExample)
RU2009123525A (ru) ПРОИЗВОДНЫЕ 5-СУЛЬФАНИЛМЕТИЛ[1,2,4}ТРИАЗОЛ[1,5-а]ПИРИМИДИН-7-ОЛА В КАЧЕСТВЕ АНТАГОНИСТОВ CXCR2
JPH10279578A5 (enExample)
RU2011103741A (ru) Композиции и способы лечения заболевания сетчатки
JP2004518723A5 (enExample)
JP2005526836A5 (enExample)
EA200300424A1 (ru) Соли изотиазол-4-карбоксамида и их применение в качестве антигиперпролиферативных агентов
JP2012521428A5 (enExample)
JP2007520440A5 (enExample)
JP2009538873A5 (enExample)
JP2002520316A5 (enExample)
RU2007111758A (ru) Аминопроизводные 7- амино-3-фенилдигидропиримидо [4,5-d] пиримидинонов, их получение и применение в качестве ингибиторов протеинкиназ
JP2006501201A5 (enExample)
JP2005511697A5 (enExample)
RU2005121908A (ru) Производные зн-хиназолин-4-она
JP2004527492A5 (enExample)
JP2020505354A5 (enExample)
JP2004507527A5 (enExample)
JP2004525183A5 (enExample)
JP2004525178A5 (enExample)
RU2007116987A (ru) Новые соединения